Detalhe da pesquisa
1.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
N Engl J Med
; 388(25): 2338-2348, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37342922
2.
Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study.
Br J Haematol
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504552
3.
ANCHOR: melflufen plus dexamethasone and daratumumab or bortezomib in relapsed/refractory multiple myeloma: final results of a phase I/IIa study.
Haematologica
; 109(3): 867-876, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646657
4.
Lenalidomide in the treatment of anti-myelin-associated glycoprotein neuropathy: A phase 1 study to identify the maximum tolerated dose.
Eur J Neurol
; 31(3): e16164, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38015467
5.
Real-world multiple myeloma risk factors and outcomes by non-Hispanic Black/African American and non-Hispanic White race/ethnicity in the United States.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031762
6.
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
Am J Hematol
; 98(1): 140-147, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35567778
7.
Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy.
Am J Ther
; 30(5): e447-e453, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713689
8.
Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study.
Br J Haematol
; 199(3): 355-365, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111391
9.
Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.
Blood
; 135(2): 97-107, 2020 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31738834
10.
Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.
Blood
; 136(8): 936-945, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325490
11.
A plain language summary of daratumumab plus lenalidomide/bortezomib/dexamethasone in transplant-eligible Black patients with newly diagnosed multiple myeloma in the GRIFFIN study.
Future Oncol
; 18(40): 4443-4456, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799429
12.
Aging Phenotypes and Restoring Functional Deficits in Older Adults With Hematologic Malignancy.
J Natl Compr Canc Netw
; 19(9): 1027-1036, 2021 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770752
13.
A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202).
Am J Hematol
; 96(12): 1595-1603, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34559902
14.
Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.
Biol Blood Marrow Transplant
; 26(8): e198-e201, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32304873
15.
Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up.
Biol Blood Marrow Transplant
; 26(1): 44-49, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31518644
16.
T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma.
Biol Blood Marrow Transplant
; 26(1): 7-15, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31445183
17.
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.
Blood
; 131(25): 2846-2855, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29545329
18.
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(12): 1685-1717, 2020 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33285522
19.
MicroRNA-155 Modulates Acute Graft-versus-Host Disease by Impacting T Cell Expansion, Migration, and Effector Function.
J Immunol
; 200(12): 4170-4179, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29720426
20.
Comparison of Two Doses of Antithymocyte Globulin in Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(10): 1993-2001, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31229641